March 27, 2019 — The U.S. Food and Drug Administration today approved Jatenzo (testosterone undecanoate), an oral testosterone capsule to treat men with certain forms of hypogonadism. These men have low testosterone levels due to specific medical…Original Article
You may also like
FDA Approves Miudella (copper intrauterine system) for...
FDA Approves Ctexli (chenodiol) for Cerebrotendinous...
FDA Approves Merilog (insulin-aspart-szjj), a...
FDA Approves Xbryk (denosumab-dssb), a Biosimilar to...
FDA Approves Ospomyv (denosumab-dssb), a Biosimilar to...
FDA Approves Penmenvy (meningococcal groups A, B, C...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.